Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0662-0419 in Participants Living With Overweight or Obesity
NCT07184632Phase 2Active, not recruiting
- Sponsor
- Novo Nordisk
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NNC0662-0419 in obesity, sponsored by Novo Nordisk. Started Oct 2025; status: active, not recruiting.
02
Drugs
NNC0662-0419
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07184632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07184632.